27 participants
Pembrolizumab and Odetiglucan in Liver Predominant Metastatic Colorectal Adenocarcinoma
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2025-09-22
- Start Date:
- 2025-09-10
- Completion:
- 2027-09-30
Conditions
- Colorectal Adenocarcinoma Metastatic in the Liver
Interventions
- DRUG
No Results Yet